Cargando…
Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden
BACKGROUND: People who inject drugs (PWID) represent a population with an increased prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach the WHO goal of eliminating HCV as a major public health threat by 2030. Despite better understanding of PWID subgroups and c...
Autores principales: | Lindqvist, K., Thorin, Z., Kåberg, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258779/ https://www.ncbi.nlm.nih.gov/pubmed/37308951 http://dx.doi.org/10.1186/s12954-023-00801-1 |
Ejemplares similares
-
Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden
por: Kåberg, Martin, et al.
Publicado: (2022) -
Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden
por: Kågström, E., et al.
Publicado: (2023) -
Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic
por: Lindqvist, K., et al.
Publicado: (2021) -
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017) -
Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan
por: Zule, William A., et al.
Publicado: (2015)